FDA Adverse Event Injury Summary report: N

FARAWAVE NAV

MDR report key: 23305476 · Received October 15, 2025

Report

Report Number
2124215-2025-67566
Event Type
Injury
Date Received
October 15, 2025
Date of Event
September 23, 2025
Report Date
November 13, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
QZI
UDI-DI
00191506043216
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Additional Manufacturer Narrative · 0

TWO (2) PHOTOGRAPHS OF INTRACARDIAC RECORDINGS WERE PROVIDED TO ASSIST IN THE INVESTIGATION AND WERE REVIEWED BY A BOSTON SCIENTIFIC QUALITY INVESTIGATOR. THE PROVIDED IMAGES SHOWED INTRACARDIAC RECORDS AFTER THE USE OF THE FARAWAVE NAV CATHETER AND TRANSIENT ST SEGMENT ELEVATION WAS NOTED POST-SHOCK. BASED ON THE INVESTIGATION AND MEDIA INSPECTION THE REPORTED ST SEGMENT ELEVATION WAS CONFIRMED.

Description of Event or Problem · 0

IT WAS REPORTED THAT ST SEGMENT ELEVATION OCCURRED. A PULSE FIELD ABLATION PROCEDURE FOR PERSISTENT ATRIAL FIBRILLATION WAS PERFORMED USING A FARAWAVE NAV CATHETER. THE FARAWAVE NAV CATHETER WAS ADVANCED THROUGH A FARADRIVE SHEATH TO THE LEFT ATRIUM. DURING THE THIRD APPLICATION OF ABLATION TO THE LEFT SUPERIOR PULMONARY VEIN ST SEGMENT ELEVATION WAS OBSERVED VIA ELECTROCARDIOGRAM LEAD AVF AND 200 MICROGRAMS OF NITROGLYCERIN WERE ADMINISTERED IN RESPONSE. THE PATIENT FULLY RECOVERED AND THE PROCEDURE WAS COMPLETED. THE PATIENT WAS DISCHARGED POST INDEX PROCEDURE.

Description of Event or Problem · 0

IT WAS REPORTED THAT ST SEGMENT ELEVATION OCCURRED. A PULSE FIELD ABLATION PROCEDURE FOR PERSISTENT ATRIAL FIBRILLATION WAS PERFORMED USING A FARAWAVE NAV CATHETER. THE FARAWAVE NAV CATHETER WAS ADVANCED THROUGH A FARADRIVE SHEATH TO THE LEFT ATRIUM. DURING THE THIRD APPLICATION OF ABLATION TO THE LEFT SUPERIOR PULMONARY VEIN ST SEGMENT ELEVATION WAS OBSERVED VIA ELECTROCARDIOGRAM LEAD AVF AND 200 MICROGRAMS OF NITROGLYCERIN WERE ADMINISTERED IN RESPONSE. THE PATIENT FULLY RECOVERED AND THE PROCEDURE WAS COMPLETED. THE PATIENT WAS DISCHARGED POST INDEX PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2694966 FARAWAVE NAV CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER QZI BOSTON SCIENTIFIC CORPORATION 0036909297 00191506043216

Patients

Seq Age Sex Outcome Treatment
1 76 YR Male Required Intervention